Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

COPD

Showing results (421-430 of 1,499) with videos related to

Pageof 150
Sort By:
COPD|February 6, 2026
The Effect of Anion Inhalation in a Mouse Model of Cigarette Smoke-Induced Chronic Obstructive Pulmonary DiseaseYuanyuan Li, Jianing Lu, Yuqin Chen, et al.
COPD|January 20, 2026
Smartphone-Enabled Cough Detection in Severely Exacerbated COPD: An Exploratory Pilot StudyMaximilian Boesch, Julia Herrmann, Florent Baty, et al.
COPD|March 27, 2025
The Experience of Automated Home Oxygen Therapy for Patients With COPD - A Qualitative StudyLinette Marie Kofod, Louise Bolvig Laursen, Elisabeth Westerdahl, et al.
COPD|February 19, 2013
Growing awareness of the importance of health literacy in individuals with COPDShiva Sadeghi, Dina Brooks, Shelley Stagg-Peterson, et al.
COPD|February 19, 2013
The COPD pipeline XXNicholas Gross
COPD|May 30, 2013
The relationship between coping styles and clinical outcomes in patients with COPD entering pulmonary rehabilitationAna Stoilkova, Emiel F M Wouters, Martijn A Spruit, et al.
COPD|May 30, 2013
Microstructural change of the brain in chronic obstructive pulmonary disease: a voxel-based investigation by MRIChang-Woo Ryu, Geon-Ho Jahng, Cheon Woong Choi, et al.
COPD|May 30, 2013
Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RSNancy K Leidy, Lindsey T Murray
COPD|July 4, 2013
Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb studyJutta Beier, Anne-Marie Kirsten, Robert Mróz, et al.
COPD|July 5, 2013
Biochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous)Robert A Sandhaus, James Stocks, Farshid N Rouhani, et al.
Pageof 150

Showing results (421-430 of 1,499) with videos related to

Sort By:
Pageof 150
COPD|February 6, 2026
The Effect of Anion Inhalation in a Mouse Model of Cigarette Smoke-Induced Chronic Obstructive Pulmonary DiseaseYuanyuan Li, Jianing Lu, Yuqin Chen, et al.
COPD|January 20, 2026
Smartphone-Enabled Cough Detection in Severely Exacerbated COPD: An Exploratory Pilot StudyMaximilian Boesch, Julia Herrmann, Florent Baty, et al.
COPD|March 27, 2025
The Experience of Automated Home Oxygen Therapy for Patients With COPD - A Qualitative StudyLinette Marie Kofod, Louise Bolvig Laursen, Elisabeth Westerdahl, et al.
COPD|February 19, 2013
Growing awareness of the importance of health literacy in individuals with COPDShiva Sadeghi, Dina Brooks, Shelley Stagg-Peterson, et al.
COPD|February 19, 2013
The COPD pipeline XXNicholas Gross
COPD|May 30, 2013
The relationship between coping styles and clinical outcomes in patients with COPD entering pulmonary rehabilitationAna Stoilkova, Emiel F M Wouters, Martijn A Spruit, et al.
COPD|May 30, 2013
Microstructural change of the brain in chronic obstructive pulmonary disease: a voxel-based investigation by MRIChang-Woo Ryu, Geon-Ho Jahng, Cheon Woong Choi, et al.
COPD|May 30, 2013
Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RSNancy K Leidy, Lindsey T Murray
COPD|July 4, 2013
Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb studyJutta Beier, Anne-Marie Kirsten, Robert Mróz, et al.
COPD|July 5, 2013
Biochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous)Robert A Sandhaus, James Stocks, Farshid N Rouhani, et al.
Pageof 150